First-of-its-kind precision medicine test to predict a cancer patient’s response to an Immune Checkpoint Inhibitor (ICI)
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
The objective behind introducing this extraordinary digital campaign is to spread awareness among Gen X and Z for the need of breast self-examination
Approximately five kg tumor was removed in the eight-hour long complicated surgery
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
Proceeds raised from the duathlon will go towards cancer treatment of children identified by the hospital
Subscribe To Our Newsletter & Stay Updated
